𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma

✍ Scribed by A. M. Attallah; A. A. Tabll; M. El-Sadany; T. A. Ibrahim; I. El-Dosoky


Publisher
Springer
Year
2003
Tongue
English
Weight
144 KB
Volume
3
Category
Article
ISSN
0372-8722

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Distribution of lymphocyte subsets and n
✍ Westermann, J. ;Pabst, R. πŸ“‚ Article πŸ“… 1992 πŸ› Springer-Verlag 🌐 English βš– 596 KB

The frequency and distribution of B and T lymphocyte subsets have been determined in many body tissues and fluids by preparing cell suspensions and tissue sections from lymphoid and nonlymphoid organs. In humans these studies often concentrate on the blood or on one particular cell source for obviou

Difference in cytotoxicity against hepat
✍ Kohei Ishiyama; Hideki Ohdan; Masahiro Ohira; Hiroshi Mitsuta; Koji Arihiro; Tos πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 308 KB

In rodents, liver natural killer (NK) cells have been shown to mediate higher cytotoxic activity against tumor cells than do peripheral blood (PB) NK cells. However, such differences between liver and PB NK cells have not been extensively investigated in humans. The phenotypical and functional prope

Blood and liver-infiltrating lymphocytes
✍ Anna BjΓΆrkland; Roger Festin; Ib Mendel-Hartvig; Anders Nyberg; Lars LΓΆΓΆf; Thoma πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 755 KB

We used two-color and three-color flow cytometric analysis to study phenotypical activation and functional subsets of T and natural killer cells in the blood and liver tissue of patients with primary biliary cirrhosis, other chronic liver diseases and the blood of healthy subjects. The changes in bl

Defective function of lymphokine-activat
✍ Toshiji Saibara; Saburo Onishi; Hiroshi Sakaeda; Yasutake Yamamoto πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 608 KB

Lymphokine-activated killer activity and natural killer activity in hepatocellular carcinoma patients were d. Maximum lymphokine-activated killer activity was induced at 3 to 6 days of incubation, and lymphokine-activated killer activity tended to increase in a manner dose dependent of recombinant i